Curriculum - Azienda Ospedaliera di Padova

CURRICULUM VITAE
INFORMAZIONI PERSONALI
Nome
Data di nascita
Qualifica
Amministrazione
Incarico attuale
ALIDA LINDA PATRIZIA CAFORIO
05/06/1959
I Fascia
AZIENDA OSPEDALIERA DI PADOVA
Staff - Cardiologia
Numero telefonico
dell’ufficio
0498212348
Fax dell’ufficio
0498761764
E-mail istituzionale
[email protected]
TITOLI DI STUDIO E
PROFESSIONALI ED
ESPERIENZE LAVORATIVE
Titolo di studio
Altri titoli di studio e
professionali
Laurea in Medicina e Chirurgia (110/110 e lode) Università di
Pisa
- Diploma di specializzazione in Malattie dell'Apparato
Cardiovascolare (70/70 e lode)Università di Pisa
- Dottorato di Ricerca (PhD) nella Facultà di Medicina,
specialità Immunologia Cardiovascolare, St. George's
Hospital Medical School Università di Londra
- Allievo della Classe di Scienze Sperimentali e Applicate,
Settore di Medicina e Chirurgia,Scuola Superiore di Studi
Universitari e di Perfezionamento S. Anna, Pisa
- Diploma di perfezionamento della Classe di Scienze
Sperimentali e Applicate, Settore di Medicina e Chirurgia
(70/70 e lode), Scuola Superiore di Studi Universitari e di
Perfezionamento S. Anna, Pisa
- 1989-90 British Heart Foundation Research Fellowship
- 1990-1991 Borsa di studio del Ministero dell' Università e
della Ricerca Scientifica e Tecnologica (MURST) per la
frequenza di corsi di specializzazione e ricerca presso
istituzioni estere di livello universitario
- 1991-1992 European Society of Cardiology Research
Fellowship
- 1993 Borsa di studio CNR Progetto Finalizzato "FAT.MA"
- 1994-95 Borsa di studio Ministero dell' Università e della
Ricerca Scientifica e Tecnologica (MURST) post-dottorato
di ricerca
1
CURRICULUM VITAE
- 1996 Premio "Attilio Reale" per la Ricerca di base in
Cardiologia;
- 2003 Premio Societa’ Italiana di Cardiologia“SCHOLAR IN
CARDIOLOGIA”- 1988-92 Assistente a tempo pieno di Cardiologia
Department of Cardiological Sciences (Prof. Alan J Camm,
Dr William J McKenna), St. George's Hospital,Università di
Londra (servizio sanitario prestato all'estero riconosciuto
con decreto del Ministero della Sanita' del 17/12/1994)
- 1988-92
Ricercatrice
(Clinical
Research
Fellow)
Department of Cardiological Sciences (Prof. Alan J Camm,
Dr William J McKenna)St. George's Hospital Medical
School,Università di Londra
- 1987 Ricercatrice onoraria (Honorary Research Fellow)
Cardiovascular Research Unit, Royal Postgraduate Medical
School,Hammersmith Hospital, Università di Londra, (Prof.
Attilio Maseri, Dr William J McKenna)
- 1993-Lettrice onoraria (Honorary Lecturer) Department of
Cardiological Sciences St. George's Hospital Medical
School,Università di Londra (Prof. William J McKenna)
- 1999-Professore a Contratto Scuola di Specializzazione in
Cardiologia I,Università degli Studi di Padova (Prof. Sabino
Iliceto)
- 2006- Titolare di Insegnamento (Esperto Esterno) In
Cardiologia
Clinica
su:
“IMMUNOLOGIA
CARDIOVASCOLARE” Scuola di Specializzazione in
Cardiologia I, IV anno Università degli Studi di Padova
(Prof. Sabino Iliceto)
- Dal 1997 al 2003 Responsabile Cardiologo del
Day-Hospital Trapianti della Cardiochirurgia Azienda
Universita’ di Padova, dedicato al follow-up di circa 500
pazienti cardiotrapiantati, comprendente anche pazienti in
eta’ pediatrica (Prof D Casarotto, Prof S Dalla Volta).
Esperienze professionali
(incarichi ricoperti)
Capacità linguistiche
Capacità nell’uso delle
tecnologie
Altro (partecipazione a
convegni e seminari,
pubblicazioni,
collaborazione a riviste,
- Incarico dirigenziale di alta specializzazione afferente
all’U.O.
di
Cardiologia:
“MIOCARDITI”
Azienda
Ospedaliera-Università di Padova (Prof. Sabino Iliceto) AZIENDA OSPEDALIERA DI PADOVA
Lingua
Inglese
Livello Parlato Livello Scritto
Eccellente
Eccellente
- Utilizzo corrente di PC (grafica, statistica, word-processing,
ricerche bibliografiche, aggiornamento) ed attrezzature
biomedicali per la diagnostica cardiologica non invasiva
(con particolare riferimento ad elettrocardiografia, ed
ecocardiografia).
- LAVORI PER EXTENSO: 122 (Dei quali con indicizzati in
Medline 97, IMPACT FACTOR TOTALE 469.057 (Impact
Factor totale calcolato da Journal citation reports-science
2
CURRICULUM VITAE
ecc., ed ogni altra
informazione che il
dirigente ritiene di dover
pubblicare)
edition del 2007). LAVORI BREVI ED ABSTRACTS DI
RELAZIONI TENUTE A CONGRESSI NAZIONALI ED
INTERNAZIONALI: 258; RELAZIONI SU INVITO A
CONGRESSI,
CONFERENZE,
CORSI
DI
AGGIORNAMENTO: 118.
- REVISORE RIVISTE SCIENTIFICHE NAZIONALI ED
INTERNAZIONALI - Italian Heart Journal -J Cardiovasc
Med - Heart - European Heart Journal - European Journal
of Heart Failure - International Journal of Cardiology Journal of the American College of Cardiology - Journal of
cellular and Molecular Medicine - Journal of Heart and Lung
Transplantation - Journal of Internal Medicine - Journal of
Immunological methods - Circulation - Clinical Cardiology Clinical and Experimental Immunology - Nature
Cardiovascular Medicine
- ISCRIZIONE A SOCIETA': Societa' Italiana di CardiologiaSocio
ordinario
1985.
European
Society
of
Cardiology-Member of Working Group on "Myocardial and
Pericardial Diseases " 1990-2009. European Society of
Cardiology-Fellow 1995. International Society for Heart and
Lung Transplantation –Member 1996. Associazione
Nazionale Medici Cardiologi Ospedalieri (A.N.M.C.O.)
–Fellow 2000. Societa' Italiana di Cardiologia-Membro del
Nucleo del Gruppo di Studio su: "Funzione Miocardica,
cardiomiopatie e Scompenso Cardiaco" 2003-2007.
Federazione Italiana di Cardiologia-Membro del Nucleo del
Gruppo di Studio su: "Scompenso Cardiaco" 2008.
Federazione Italiana di Cardiologia-Vice-Coordinatore del
Gruppo di Studio su: " Cardiomiopatie " 2008.
- LAVORI PER EXTENSO 1)Sighieri C, Cecchini M, Zucchi
R, Petronio AS, Gherarducci G, Caforio ALP, Poddighe R,
Mariani M: Embolia sistemica nei portatori di protesi
valvolari cardiache: fattori predisponenti e influenza della
terapia anticoagulante. Cardiologia 1985; 30: 617-622
- 2)Frennaux MP, Porter A, Caforio ALP, Odawara H,
Counihan PJ, McKenna WJ: Determinants of exercise
capacity in hypertrophic cardiomyopathy. J Am Coll Cardiol
1989; 13: 1521-1526 I.F. 11.054
- 3) Caforio ALP, Rossi B, Risaliti R, Siciliano G, Marchetti A,
Angelini C, Crea F, Mariani M, Muratorio A: Type 1 fiber
abnormalities in skeletal muscle of patients with
hypertrophic and dilated cardiomyopathy: evidence of
subclinical myogenic myopathy. J Am Coll Cardiol 1989; 14;
1464-73 I.F. 11.054
- 4)Caforio ALP, Bonifacio E, Stewart JT, Neglia D, Parodi O,
Bottazzo GF, McKenna WJ: Novel organ-specific circulating
cardiac autoantibodies in dilated cardiomyopathy. J Am Coll
Cardiol 1990; 15: 1527-34 I.F. 11.054
- 5)Caforio ALP, Stewart JT, Bonifacio E, M Burke, Davies
MJ, McKenna WJ, Bottazzo GF: Inappropriate Major
Histocompatibility Complex expression on cardiac tissue in
3
CURRICULUM VITAE
dilated cardiomyopathy. Relevance for autoimmunity? J
Autoimmun 1990; 3: 187-200 I.F. 3.391
- 6)McKenna WJ, Caforio ALP: What is myocarditis? In Shaw
D, Hampton J, editors, Medicine International. Oxford:
Medicine Education (International) Ltd 1989; 67: 2801
- 7) Caforio ALP, Stewart JT, McKenna WJ: Idiopathic dilated
cardiomyopathy. Rational treatment awaits better
understanding of pathogenesis. Brit Med J 1990; 300:
890-91 I.F. 9.723
- 8) Caforio ALP, Bottazzo GF, McKenna WJ, Counihan PJ,
Burke M, Davies MJ, Pepper JR: Class II Major
Histocompatibility
Complex
Antigens
on
cardiac
endothelium: an early biopsy marker of rejection in the
transplanted human heart. Transplant P 1990; 22:
1830-1833.
- 9) Caforio ALP: Miocardiopatia dilatativa: quadro clinico,
ipotesi patogenetiche ed implicazioni terapeutiche. Primary
Cardiology 1990; 5 (3): 185-189
- 10) Frennaux MP, Counihan PJ, Caforio ALP, Chikamori T,
McKenna WJ: Abnormal blood pressure response in
hypertrophic cardiomyopathy. Circulation 1990; 82:
1995-2002 I.F. 12.755
- 11) Caforio ALP, McKenna WJ: Dilated cardiomyopathy:
chronic viral infection or autoimmune disease? A critical
view of the viral and the autoimmune hypothesis. Indian
Heart Journal 1990; 42:399-402
- 12) Stewart JT, Caforio ALP, McKenna WJ: Ventricular
arrhythmias in dilated cardiomyopathy. L' Information
Cardiologique 1990: 14: 798-801
- 13) Caforio ALP, Wagner R, Gill JR, Bonifacio E, Bosi E,
Miles A, McKenna WJ, Bottazzo GF: Organ-specific cardiac
autoantibodies: new serological markers for systemic
hypertension in autoimmune polyendocrinopathy. Lancet
1991 337:1111-15
- 14) Alfonso F, Caforio ALP, Del Toro J, Torrecilla E, Rey M,
De Rabago P: Right ventricular dilated cardiomyopathy
associated with primary biliary cirrhosis. Eur Heart J
1991;12: 1240-43. I.F. 7.924
- 15) Caforio ALP, Bonifacio E, Keeling PJ, Grazzini M,
Schiaffino S, Bottazzo GF, McKenna WJ: Cardiomiopatia
dilatativa idiopatica: infezione virale persistente o malattia
autoimmune organo-specifica? Processo alle due ipotesi
patogenetiche maggiori. Giornale Italiano di Cardiologia
1992; 22: 63-72
- 16) Keeling PJ, Caforio ALP: The assessment of viral and
immune mediated pathogenesis in dilated cardiomyopathy.
In Oto A, editor, Current practice of cardiology (Proceedings
of the 4th annual Meeting of the Mediterranean association
4
CURRICULUM VITAE
of Cardiology and Cardiac Surgery and the 3rd International
Symposium on Cardiac Pacing and Electrophysiology.
September 23-30, 1990. Antalya, Turkey) , Mount Kisco:
Futura media services, inc. 1991; 69-78.
- 17) Caforio ALP, Goodwin JF: Current insights into the
pathogenesis and treatment of dilated cardiomyopathy.
Primary Cardiology 1992; 18: 37-48.
- 18) Caforio ALP, Grazzini M, Mann JM, Keeling PJ,
Bottazzo GF, McKenna WJ, Schiaffino S: Identification of
the a and b myosin heavy chain isoforms as major
autoantigens in dilated cardiomyopathy. Circulation 1992;
85: 1734-42 I.F. 12.755
- 19) Caforio ALP, Martinetti M, Bonifacio E, Gavazzi A,
Graziano G, Cuccia MC, Lorini R, McKenna WJ, Bottazzo
GF: Idiopathic dilated cardiomyopathy: lack of association
between organ-specific cardiac antibodies and HLA-DR
antigens. Tissue Antigens 1992; 39 (5): 236-40 I.F. 2.245
- 20) Jennison SH, Caforio ALP, Fashola T, Riley S, Holt
DW. The use of interleukin-2 receptor levels in cardiac
transplant recipients. (letter) Transplantation 1992; 53 (4):
954-55 I.F. 3.691
- 21) Keeling PJ, Jeffrey S, Caforio ALP, Taylor R, Bottazzo
GF, Davies MJ, McKenna WJ: Similar prevalence of
enteroviral genome within the myocardium from patients
with idiopathic dilated cardiomyopathy and controls by the
polymerase chain reaction. Br Heart J 1992; 68: 554-559
I.F. 4.141
- 22) Martinetti M, Dugoujon JM, Caforio ALP, Schwarz G,
Gavazzi A, Graziano G, Arbustini E, Lorini R, McKenna WJ,
Bottazzo GF, Cuccia M. HLA antigens and immunoglobulin
polymorphisms in idiopathic dilated cardiomyopathy. Hum
Immunol 1992; 35: 193-199. I.F. 2.901
- 23) Zachara E, Caforio ALP, Carboni GP, Pellegrini A,
Pompili A, Del Porto G, Sciarra A, Bosman C, Boldrini R,
Prati Pl, McKenna WJ. Familial aggregation of idiopathic
dilated cardiomyopathy: clinical features and pedigree
analysis in 14 families. Br Heart J 1993; 69: 129-35. I.F.
4.141
- 24) Keeling PJ, Lukaszyk A, Poloniecki J, Caforio ALP,
Davies MJ, Booth JC, McKenna WJ: A prospective
case-control study of antibodies to Coxsackie-B virus in
idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994;
23: 593-8 I.F. 11.054
- 25) Caforio ALP, Keeling PJ, Zachara E, Mestroni L,
Camerini F, Mann JM, Bottazzo GF, McKenna WJ.
Evidence from family studies for autoimmunity in dilated
cardiomyopathy. Lancet 1994; 344: 773-777 I.F. 28.638
- 26) Caforio ALP, Keeling PJ, McKenna WJ: Autoimmune
pathogenesis of dilated cardiomyopathy. An overview.
5
CURRICULUM VITAE
Cardioscopies 1995; 29: 454-582
- 27) Schiaffino S, Caforio ALP, Di Lisa F. Biochimica e
biologia
molecolare
nello
studio
della
biopsia
endomiocardica. In Baroldi G, Thiene G: "Biopsia
endomiocardica. Testo-atlante", Piccin Ed, Padova 1996:
321-325
- 28) Livi U, Caforio ALP, Grassi G, Boffa GM, Gambino A,
Milano A, Bianco R, Casula R, Thiene G, Casarotto D.
Mid-term results of heart transplantation in diabetic patients.
J Cardiovasc Surg 1994; 35 (Suppl 1 to No. 6): 115-8. I.F.
1.570
- 29) Milano A, Livi U, Caforio ALP, Bianco R, Casula R,
Gambino A, Feltrin G, Legittimo A, Angelini A, Thiene G,
Casarotto D. The behaviour of "Grade 2" ISHLT cardiac
rejection. Transplant P 1994; 26(5): 2724 I.F. 1.027
- 30) Livi U, Milano A, Caforio ALP, Grassi G, Feltrin G, Boffa
GM, D'Agnolo A, Bianco R, Angelini A, Thiene G, Casarotto
D. Influence of rejection on late graft function after heart
transplantation. Transplant P 1994; 26 (5): 2727-28 I.F.
1.027
- 31) Caforio ALP: Role of autoimmunity in dilated
cardiomyopathy. Br Heart J 1994; 72 (Supplement)
S30-S34. I.F. 4.141
- 32) Marcolongo R, Laveder F, Caforio ALP. Cuore e vasi
nelle malattie da alterata immunoregolazione. In Dalla Volta
S, ed. Malattie del cuore e dei vasi. Milano: McGraw-Hill,
1996: 617-39
- 33) Livi U, Caforio ALP, Grassi G, Boffa GM, Barchitta A,
Gambino A, Thiene G, Casarotto D. Heart transplantation
for end-stage valvular disease. Transplant P 1995; 27 (1):
1305-06 I.F1.027
- 34) Keeling PJ, Gang Y, Smith G, Seo H, Bent SE, Murday
V, Caforio ALP, McKenna WJ. Familial dilated
cardiomyopathy in the United Kingdom. Br Heart J 1995; 73
(5): 417-21 I.F. 4.141
- 35) Caforio ALP, Jonathan H Goldman, M. Kamran Baig,
Keeling PJ, Bottazzo GF, McKenna WJ: Organ-specific
cardiac autoantibodies in dilated cardiomyopathy-an
update. Eur Heart J 1995; 16 (Suppl. 0): 68-70 I.F. 7.924
- 36) Bilinska ZT, Caforio ALP, Grzybowski J, Michalak E,
Kusmierczyc- Droszcz B, Goldman JH, Haven LH,
Rydlewska-Sadowska W, McKenna WJ, Ruzyllo W.
Organ-specific
cardiac
autoantibodies
in
dilated
cardiomyopathy: frequency and clinical correlates in Polish
patients. Eur Heart J 1995; 16: 1907-11. I.F. 7.924
- 37) Livi U, Caforio ALP, Boffa GM, Tursi V, Thiene G,
Casarotto D. Mid-term results of heart transplantation for
end-stage valvular disease. Eur J Cardio-Thorac 1995; 9:
6
CURRICULUM VITAE
521-25. I.F. 2.011
- 38) Keeling PJ, Goldman JH, Slade AKB, Elliott PM,
Caforio ALP, Poloniecki J, McKenna WJ. Prognosis of
idiopathic dilated cardiomyopathy at a referral center. J
Cardiac Failure 1995; 1 (5): 1-9. I.F. 3.067
- 39) Goldman JH, Warraich RS, Keeling PJ, Redwood S,
Baig KM, Elliott PM, Dalla Libera L, Sanderson JE, Caforio
ALP, McKenna WJ. Autoimmunity to a-myosin in a subset
of patients with idiopathic dilated cardiomyopathy. Br Heart
J 1995; 74: 598-603 I.F. 4.141
- 40) Livi U, Caforio ALP, Tursi V, Boffa GM, Borrelli MR,
Bauce B, Thiene G, Casarotto D. Donor age greater than
50 years does not influence mid-term results of heart
transplantation. Transplant P 1996; 28 (1): 91-92 I.F. 1.027
- 41) Caforio ALP, Jonathan H Goldman, Aldwyn J Haven, M.
Kamran Baig, McKenna WJ: Evidence for autoimmunity to
myosin and other heart-specific autoantigens in patients
with dilated cardiomyopathy and their relatives. Int J Cardiol
1996; 54 (2): 157-63 I.F. 2.878
- 42) Milano A, Caforio ALP, Livi U, Bauce B, Angelini A,
Casarotto D, Thiene G. Evolution of focal moderate (ISHLT
grade 2) rejection of the cardiac allograft. J Heart Lung
Transpl 1996; 15 (5): 456-60 I.F. 3.087
- 43) Caforio ALP, McKenna WJ: Recognition and optimum
management of myocarditis. Drugs 1996; 52 (4): 515-25
I.F. 3.726
- 44) Bilinska ZT, Caforio ALP, Kusmierczyc-Droszcz B,
Michalak E, Grzybowski J, Goldman JH, Haven AJ,
Rydlewska-Sadowska W, McKenna WJ, Ruzyllo W.
Increased frequency of organ-specific cardiac antibodies in
healthy relatives of patients with dilated cardiomyopathy:
evidence for autoimmunity in Polish families. Clin Cardiol
1996; 19: 794-98 I.F. 1.067
- 45) Thiene G, Angelini A, Basso C, Caforio ALP, Calabrese
F, Corrado D, Rampazzo A, Valente M. Patologia e
patogenesi della cardiomiopatia aritmogena del ventricolo
destro. In Delise P, "Atti del Convegno Nazionale di
Cardiologia dello Sport. Confini tra normalita' e patologia
nel cuore dello sportivo", Venezia-S. Giuliano, 1-2
Novembre 1996: 147-49.
- 46) Caforio ALP: Autoimmunity in myocarditis and dilated
cardiomyopathy. In Puddu PE, Bing RJ, Campa PP,
Poole-Wilson PA, editori: Congestive heart failure: from
basic science to therapeutics. Cardioricerca Ed, Roma
1997: 153- 178.
- 47) Betterle C, Spadaccino A.C., Pedini B, Caforio ALP.
Autoanticorpi nelle malattie autoimmuni del muscolo
scheletrico, della giunzione neuro-muscolare, e del cuore.
In Betterle C, Gli autoanticorpi. Manuale-Atlante a colori di
7
CURRICULUM VITAE
diagnostica. Padova: Piccin Editore, 1997: 313-37.
- 48) Caforio ALP, Goldman JH, Baig KM, Haven AJ, Dalla
Libera L, Keeling PJ, McKenna WJ. Cardiac autoantibodies
in dilated cardiomyopathy become undetectable with
disease progression. Heart 1997; 77: 62-67 I.F. 4.141
- 49) Caforio ALP, Goldman JH, Haven AJ, Baig KM, Dalla
Libera L, McKenna WJ. Circulating cardiac autoantibodies
as markers of autoimmunity in clinical and biopsy-proven
myocarditis. Eur Heart J 1997; 18: 270-75 I.F. 7.924
- 50) Caforio ALP: Postviral autoimmune heart disease: fact
or fiction? Eur Heart J 1997; 18: 1051-55 I.F. 7.924
- 51) Hossein-Nia M, Baig MK, Goldman JH, Keeling PJ,
Caforio ALP, Holt DW, McKenna WJ. Creatine kinase
isoforms as circulating markers of deterioration in idiopathic
dilated cardiomyopathy. Clin Cardiol 1997; 20 (1): 55-60 I.F.
1.067
- 52) Caforio ALP, Bauce B, Boffa G M, De Cian F, Angelini
A, Melacini P, Razzolini R, Fasoli G, Chioin R, Schiaffino S,
Thiene G, Dalla Volta S. Autoimmunity in myocarditis and
dilated cardiomyopathy: cardiac autoantibody frequency
and clinical correlates in a patient series from Italy. G Ital
Cardiol 1997; 227: 106-112.
- 53) Livi U, Caforio ALP, Guzzi G, Feltrin G, Boffa GM,
Angelini A, Casarotto D. Impact of organ preservation
techniques in the era of donor pool expansion. Transplant P
1997; 29: 3382-83. I.F. 1.027
- 54) Baig MK, Salomone O, Caforio ALP, Goldman JH,
Amuchastegui M, Caiero T, McKenna WJ: Human
Chagasic disease is not associated with antiheart humoral
response. Am J Cardiol 1997; 79: 1135-37 I.F. 3.603
- 55) Baig MK, Goldman JH, Caforio ALP, Coonar AS,
Keeling PJ, McKenna WJ. Familial dilated cardiomyopathy:
cardiac abnormalities are common in asymptomatic
relatives and may represent early disease. J Am Coll
Cardiol 1998; 31(1): 195-201. I.F. 11.054
- 56) Caforio ALP, Goldman JH, Haven AJ, Baig MK,
McKenna WJ: Organ- specific cardiac autoantibodies in
dilated
cardiomyopathy:
pathogenetic
implications.
Proceedings of the 2nd Florence meeting on "Advances in
cardiomyopathies". Springer Verlag 1998; 101-106
- 57) Livi U, Caforio ALP, Tursi V, Brombin M, Feltrin G,
Angelini A, Casarotto D. Heart transplantation in patients
with neoplastic disease. G Ital Cardiol 1997; 27: 11-12 .
- 58) Baig K, Mahon N, McKenna WJ, Caforio ALP, Bonow
R, Francis G, Gheorghiade M. The pathophysiology of
advanced heart failure. Am Heart J 1998; 135(6 Pt 2Su):
S216-S230. I.F. 3.649
- 59) Livi U, Caforio ALP, Gambino A, Tursi V, Milanesi O,
8
CURRICULUM VITAE
Stellin G, Angelini A, Casarotto D. Cyclosporine-based
steroid-free therapy in pediatric heart transplantation: long
term results. Transplant P 1998; 30 (5): 1975-76 I.F 1.027
- 60) Caforio ALP, Tursi V, Brombin M, Feltrin G, Angelini A,
Livi U. Heart transplantation in patients with neoplastic
disease. Transplant P 1998; 30 (5) 1928 I.F. 1.027
- 61) Currie PF, Goldman JH, Caforio ALP, Jacob AJ, Baig
KM, Brettle RP, Haven AJ, Boon NA, McKenna WJ.
Evidence of cardiac autoimmunity in HIV related heart
muscle disease. Heart 1998; 79 (6): 599-604. I.F. 4.141
- 62) Livi U, Caforio ALP, Feltrin G, Gambino A, Milanesi O,
Casarotto D. Organ and somatic growth after heart
transplantation. In Livi U, Thiene G, Casarotto D, eds: Heart
transplantation in Italy. Masson, Milano 1999: 191-195.
- 63) de Leeuw N, Melchers WJG, Ruiter DJ, Caforio ALP,
Balk AHMM, de Jonge N, Galama JMD. Autoimmune
markers are undetectable in end-stage idiopathic dilated
cardiomyopathy. J Clin Pathol 1999; 52: 739-43 I.F. 2.426
- 64) Mestroni L, Rocco C, Gregori D, Sinagra G, Di Lenarda
A, Miocic S, Vatta M, Pinamonti B, Muntoni F, Caforio ALP,
McKenna WJ, Falaschi A, Giacca M, Camerini F, and the
Heart Muscle Disease Study Group. Familial dilated
cardiomyopathy: evidence for genetic, phenotypic and
etiologic heterogeneity. J Am Coll Cardiol 1999; 34 (1):
181-90 I.F. 11.054
- 65) Caforio ALP. Le miocarditi. G Ital Cardiol 1999; 29 (10):
1169-70.
- 66) Belloni-Fortina A, Caforio ALP, Piaserico S, Alaibac
MSA, Tona F, Feltrin G, Livi U, Peserico A. Skin cancer in
heart transplant recipients: frequency and risk factor
analysis. J Heart Lung Transplant 2000; 19 (3): 249-55. I.F.
3.087
- 67) Caforio ALP, Belloni-Fortina A, Piaserico S, Alaibac
MSA, Tona F, Feltrin G, Pompei E, Testolin L, Gambino A,
Dalla Volta S, Thiene G, Casarotto D, Peserico A. Skin
cancer in heart transplant recipients: risk factor analysis
and relevance of immunosuppressive therapy. Circulation
2000; 102 (Suppl III): III-222-III-227. I.F. 12.755
- 68) Livi U, Caforio ALP. Heart donor management and
expansion of current selection criteria. J Heart Lung
Transplant 2000; 19 (8S): S43-S48. I.F. 3.087
- 69) Buda A, Caforio ALP, Calabrese F, Fagiuoli S, Pevere
S, Livi U, Naccarato R, Burra P. Lymphoproliferative
disorders in heart transplant recipients: role of hepatitis C
virus (HCV) and Epstein-Barr (EBV) infection. Transplant
Int 2000; 13 (Suppl 1): S402-405. I.F. 2.3
- 70) Melacini P, Gambino A, Caforio ALP, Bressan M,
Valente ML, Angelini A, Fanin M, Thiene G, Angelini C,
9
CURRICULUM VITAE
Casarotto D, Danieli GA, Dalla Volta S. Heart
transplantation in patients with end-stage cardiomyopathy :
molecular –biochemical defects on cardiac and skeletal
muscle. Transplant P 2001:33; 1596-99 I.F. 1.027
- 71) Caforio ALP, Belloni Fortina A, Gambino A, Piaserico S,
Feltrin G, Tona F, Pompei E, Testolin L, Gai F, Angelini A,
Casarotto D, Peserico A. High rejection score in the first
year and risk of skin cancer in heart transplantation.
Transplant P 2001:33;1608-09 I.F. 1.027
- 72) Caforio ALP, Gambino A, Belloni Fortina A, Piaserico S,
Scarpa E, Feltrin G, Tona F, Pompei E, Tonin E, Amadori
G, Thiene G, Dalla Volta S, Peserico A, Casarotto D.
Monoclonal gammopathy in heart transplantation: risk factor
analysis and relevance of immunosuppressive load.
Tranplant P 2001:33;1583-84 I.F. 1.027
- 73) Maraglino G, Caforio ALP. Complicanze cardiologiche
nei trapianti d’organo. In Naccarato R, Burra P, ed:
Complicanze mediche nei trapianti d’organo. Piccin,
Padova 2001; 25-40.
- 74) Caforio ALP, Gambino A, Tona F, Feltrin G, Marchini F,
Pompei E, Testolin L, Angelini A, Dalla Volta S, Casarotto
D. Sulfinpyrazone reduces Cyclosporine A levels: a new
drug interaction in heart transplant recipients. J Heart Lung
Transplant 2000; 19 (12): 1205-1208. I.F. 3.087
- 75) Dall’Amico R, Montini G, Murer L, Andreetta B,
Zacchello G, Gambino A, Feltrin G, Caforio ALP, Tursi V,
Livi U. Extracorporeal photochemotherapy after cardiac
transplantation : a new therapeutic approach to allograft
rejection. Int J Artif Organs 2000; 23 (1): 49-54. I.F. 1.277
- 76) Caforio ALP, Goldman JH, Baig KM, Mahon NJ, Haven
AJ, Souberbielle BE, Holt D W, Dalgleish AJ, McKenna WJ.
Elevated serum levels of soluble interleukin-2 receptor,
neopterin and b2 -microglobulin in idiopathic dilated
cardiomyopathy: relation to disease severity and
autoimmune pathogenesis. Eur J Heart Fail 2001; 3 (2):
155-163 I.F. 2.986
- 77) Caforio ALP, Mahon NJ, McKenna WJ. Cardiac
autoantibodies to myosin and other heart-specific
autoantigens in myocarditis and dilated cardiomyopathy.
Autoimmunity, (special issue on “Update on Cardiac
Autoimmunity”). 2001; 34 (3):199-204 I.F. 2.887
- 78) Gambino A, Testolin G, Gerosa G, Feltrin G, Caforio
ALP, Iacona GM, Spagna E, Casarotto D. New trend s in
transplantation. Tranplant P 2001:33;1583-84 I.F. 1.027
- 79) Caforio ALP , Betterle C. Malattie autoimmuni e
immunomediate del cuore. In Betterle C, Le malattie
autoimmuni. Padova: Piccin Editore, 2001: 353-67.
- 80) Boffa GM, Caforio ALP, Livi U. Trapianto cardiaco. In
Dalla Volta S, ed. Manuale delle malattie del cuore e
10
CURRICULUM VITAE
dell’aorta. Seconda Ed.Milano: McGraw-Hill, 2001:273-282
- 81) Marcolongo R, Laveder F, Rigoli AM, Caforio ALP.
Cuore e vasi nelle malattie autoimmuni e da alterata
immunoregolazione. In Dalla Volta S, ed. Manuale delle
Malattie del cuore e dell’aorta. Seconda Ed.Milano:
McGraw-Hill, 2001:723-732
- 82) Caforio ALP, Tona F, Boffa GM, Daliento L, Bellotto F,
Maddalena F, Ramondo A, Chioin R, Calabrese F, Angelini
A, Nava A, Thiene G. Indicazioni allargate alla biopsia
endomiocardica. In Cardiologia 2001. Atti del XXXV
Convegno internazionale del Dipartimento Cardiologico A.
De Gasperis, Milano, 24-28 Settembre 2001:258-264
- 84) Mahon NG, Madden B, Caforio ALP, Haven AJ, Elliott
PM,
Keogh
BE,
Davies
MJ,
McKenna
WJ.
Immunohistochemical evidence of myocardial disease in
apparently healthy relatives of patients with dilated
cardiomyopathy. J Am Coll Cardiol 2002; 39 (3): 455-62 I.F.
11.054
- 85) Caforio ALP, Mahon NJ, Tona F, McKenna WJ.
Circulating
cardiac
autoantibodies
in
dilated
cardiomyopathy and myocarditis: pathogenetic and clinical
significance. European Journal of Heart Failure. 2002; 4 (4):
411-17 I.F. 2.986
- 86) Daliento L, Calabrese F, Tona F, Caforio ALP, Tarsia
G, Angelini A, Thiene G. Successful treatment of
Enterovirus-induced myocarditis with interpheron alpha. J
Heart Lung Transplant 2003; 22: 214-17 I.F. 3.087
- 87) Mahon NG, Caforio ALP, McKenna WJ. Abnormal
cellularity in asymptomatic relatives of patients with
idiopathic dilated cardiomyopathy (letter) J Am Coll Cardiol
2003; 41 (4): 709 I.F. 11.054
- 88) Caforio ALP, Mahon NG, McKenna WJ.
Immunosuppressive
treatment
in
familial
dilated
cardiomyopathy
with
biopsy-proven
intramyocardial
inflammation? (letter) J Am Coll Cardiol 2003: 41 (1):169-71
IF. 11.054
- 89) Fagiuoli S, Pevere S, Minniti F, Livi U, Caforio ALP,
Naccarato R, Chiaramonte M. Natural leucocyte interferon
alfa for the treatment of chronic hepatitis in heart transplant
recipients. Transplantation 2003: 75 (7): 982-86 I.F. 3.641
- 90) Caforio ALP, Tona F, McKenna WJ. Organ-specific
autoimmunity involvement in cardiovascular disease. In
Doria, Pauletto P, eds. The heart in systemic autoimmune
diseases. New York: Elsevier, 2004 1: 19-39
- 91) Caforio ALP, Tona F, Belloni-Fortina A, Angelini A,
Piaserico S, Gambino A, Feltrin G, Ramondo A, Valente
ML, Iliceto S, Thiene G, Gerosa G. Immune and
nonimmune predictors of cardiac allograft vasculopathy:
multivariate
risk
factor
analysis
and
role
of
11
CURRICULUM VITAE
immunosuppression. Am J Transplant 2004: 4: 962-70 I.F.
6.423
- 92) Belloni-Fortina A, Piaserico S, Caforio ALP, Abeni D,
Alaibac M, Angelini A, Iliceto S, Peserico A.
Immunosuppressive level and other risk factors for basal
cell carcinoma and squamous cell carcinoma in heart
transplant recipients. Arch Dermatol 2004 140: 1079-85 I.F.
2.845
- 93) Caforio ALP, Tona F, Piaserico S, Gambino A, Feltrin
G, Belloni Fortina A, Angelini A, Alaibac M, Bontorin M,
Calzolari D, Peserico A, Thiene G, Iliceto S, Gerosa G. C2
is superior to C0 as predictor of renal toxicity and rejection
risk profile in stable heart transplant patients. Transplant Int
2005: 18: 116-124 I.F. 2.300
- 94) Tona F, Caforio ALP, Piaserico S, Bontorin M, De
Simone G, Leone MG, Belloni Fortina A, Gambino A, Feltrin
G, Calzolari D, Angelini A, Peserico A, Thiene G, Gerosa G,
Iliceto S. Abnormal total ejection isovolume index as early
non-invasive marker of chronic cardiac allograft dysfunction
in heart transplantation. Transplant Int 2005: 18: 303-308
I.F. 2.300
- 95) Belloni Fortina A, Piaserico S, Alaibac M, Caforio ALP,
Brandolisio L, Zacchello G, Zanon G, Zancan L, Peserico A.
Skin disorders in patients transplanted in childhood.
Transplant Int 2005: 18: 360-365 I.F. 2.300
- 96) Boffa GM, Caforio ALP, Gambino A, Tona F, Gerosa G.
Trapianto cardiaco. In Dalla Volta S, Daliento L, Razzolini
R, eds. Manuale delle malattie del cuore e dei vasi. Terza
ed. Milano: McGraw-Hill, 2005: 263-271
- 97) Marcolongo R, Carmello R, Tona F, Caforio ALP. Cuore
e vasi nelle malattie autoimmuni e altre patologie
immunomediate. In Dalla Volta S, Daliento L, Razzolini R,
eds. Manuale delle Malattie del cuore e dei vasi. Terza ed.
Milano: McGraw-Hill, 2005: 653-669
- 98) Melacini P, Boffa GM, Nava A, Tona F, B Bauce,
Caforio ALP. Malattie del miocardio. In Dalla Volta S,
Daliento L, Razzolini R, eds. Manuale delle malattie del
cuore e dei vasi. Terza ed. Milano: McGraw-Hill, 2005:
447-472
- 99) Caforio ALP, Mahon NJ, McKenna WJ. Clinical
implications
of
anti-cardiac
immunity
in
dilated
cardiomyopathy. In Ernst Schering Research Foundation
Workshop 55. Editors: HP Schultheiss, JF Kapp, Grotzbach
G. Chronic viral and inflammatory cardiomyopathy. Berlin:
Springer-Verlag, 2005: 169-93
- 100) Mahon NG, Murphy RT, MacRae C, Caforio ALP,
Elliott PM, McKenna WJ. Echocardiographic screening in
asymptomatic relatives of dilated cardiomyopathy patients
reveals preclinical disease. Ann Intern Med, 2005;
143;108-115 I.F. 15.516
12
CURRICULUM VITAE
- 101) Caforio ALP, Daliento L, Angelini A, Bottaro S, Vinci A,
Dequal G, Tona F, Iliceto S, Thiene G, McKenna WJ.
Autoimmune myocarditis and dilated cardiomyopathy: focus
on cardiac autoantibodies. Lupus, 2005; 14(9):652-5 I.F.
2.248
- 102) Brucato A, Shinar Y, Brambilla G, Robbiolo L, Ferrioli
G, Patrosso MC, Zanni D, Penco S, Boiani E, Ghirardello A,
Caforio ALP, Bergantin A, Tombini V, Moreo A, Doria A,
Shoenfeld Y, Livneh A. Idiopathic recurrent acute
pericarditis: absence of familial Mediterranean fever
mutations, new rheumatological diseases, HLA typing.
Lupus, 2005; 14 (9):670-4 I.F. 2.248
- 103) Nelson PN, Astley SJ, Roden D, Waldron E, Baig K,
Caforio ALP, Koutetakis Y, Perera S, Spry C.
Characterisation of Anti-Myosin Monoclonal Antibodies.
Hybridoma 2005; 24(6):314-8 I.F. 0.294
- 104) Tona F, Caforio ALP, Montisci R, Angelini A, Ruscazio
M, Gambino A, Ramondo A, Thiene G, Gerosa G, Iliceto S.
Coronary-flow reserve by contrast-enhanced transthoracic
echocardiography: a new non invasive diagnostic tool for
cardiac allograft vasculopathy. Am J Transplant, 2006;
6:998-1003 I.F. 6.423
- 105) Tona F, Caforio ALP, Montisci R, Gambino A, Angelini
A, Ruscazio M, Toscano G, Feltrin G, Ramondo A, Gerosa
G, Iliceto S. Coronary flow velocity pattern and
coronary-flow reserve by contrast-enhanced transthoracic
echocardiography predict long-term outcome in heart
transplantation. Circulation, 2006; 114 (Suppl I): I49-I-55
I.F. 12.755
- 106) Caforio ALP, Tona F, Iliceto S. Cardiomiopatie e
malattie del muscolo scheletrico. Cardiologia 2006, J
Medical Books, Editors, Viareggio: 385-91
- 107) Burra P, Buda A, Livi U, Rigotti P, Zanus G, Calabrese
F, Caforio AL,MeninC, Canova D, Farinati F, Aversa LSM.
Occurrence of post-transplant lymphoproliferative disorders
among over thousand adult recipients: any role for hepatitis
C infection? Eur J Gastroenterol Hepatol 2006; 18: 1065-70
I.F. 1.830
- 108) Caforio ALP, Mahon NG, Baig KM, F Tona, Murphy
RT, Elliott PM, McKenna WJ. Prospective familial
assessment
in
dilated
cardiomyopathy:
cardiac
autoantibodies
predict
disease
development
in
asymptomatic relatives. Circulation, 2007; 115: 76-83 I.F.
12.755
- 109) Caforio ALP, Calabrese F, Angelini A, Tona F, Vinci A,
Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G,
Daliento L. A prospective study of biopsy-proven
myocarditis: prognostic relevance of clinical and
etiopathogenetic features at diagnosis. Eur Heart J , 2007;
28 (11):1326-33 I.F. 7.924
13
CURRICULUM VITAE
- 110) Angelini A, Castellani C, Tona F, Gambino A, Caforio
ALP, Feltrin G, Della Barbera M, Valente ML, Gerosa G,
Thiene G. Continuous engraftment and differentiation of
male recipient Y-Chromosome-positive cardiomyocytes in
donor female human heart transplants. J Heart Lung
Transplant, 2007; 26 (11):1110-18 I.F. 3.087
- 111) Caforio ALP, Angelini A. Dilated cardiomyopathy and
myocarditis: classification, pathological, clinical and
autoimmune
features.
XII
Congresso
Nazionale
FADOI,16-19 maggio 2007, Abstract Book; 119-121
- 112) Caforio ALP, Tona F, Bottaro S, Vinci A, Daliento L,
Thiene G, Iliceto S. Clinical implications of anti-heart
autoantibodies in myocarditis and dilated cardiomyopathy.
Autoimmunity 2008; 41 (1):35-45 I.F. 2.887
- 113) Caforio ALP, Iliceto S. Genetically-determined
myocarditis. Clinical presentation and immunological
characteristics. Curr Opin Cardiol 2008; Cardiol 2008;
23:219-26 I.F. 2.504
- 114) Caforio ALP, Vinci A, Iliceto S. Anti-heart
autoantibodies in familial dilated cardiomyopathy.
Autoimmunity 2008; 41 (6):462-69 I.F. 2.887
- 115) Tona F, Caforio ALP, Iliceto S. Microvascular
dysfunction in left apical ballooning syndrome: Primary
cause or secondary phenomenon? Eur J Echocardiogr.
2007 ;8:411-2.
- 116) Brambilla G, Brucato A, Adler Y, Bosetti M, Coppini P,
Caforio ALP, Spodick D, Canesi B. Recurrent acute
idiopathic
pericarditis:
rheumatologic
therapy,
autoantibodies and long term outcome. Reumatismo.
2007;59:25-31
- 117) Pahl E, Caforio ALP, Kuhn MA. Allograft
vasculopathy:detection, risk factors, natural history, and
treatment. In Canter CE, S, Kirklin JK, eds. Pediatric heart
transplantation ISHLT monograph series, Volume 2.
Philadelphia: Elsevier, 2007: 173-185; ISSN 1930-2134
- 118) Caforio ALP, Tona F, Vinci A, Calabrese F, Ramondo
A, L Cacciavillani, Corbetti F, Leoni L, Thiene G, Iliceto S,
Angelini A. Acute biopsy-proven lymphocytic myocarditis
mimicking Takotsubo cardiomyopathy. Eur J Heart Fail ;
2009; 11:428-31 I.F. 2.986
- 119) Osto E, Tona F, Angelini A, Montisci, R, Ruscazio, M,
Vinci A, Tarantini G, Ramondo, A, Gambino G, Thiene G,
Caforio A, Gerosa G, Iliceto S. Determinants of coronary
flow reserve in heart transplantation: a study performed with
contrast-enhanced echocardiography. J Heart Lung
Transplant; 2009 ; 28 (5):453-60 I.F. 3.087
- 120) Angelini A, Castellani C, Poli F, Benazzi E,
Torregrossa G, Tona F, Gambino A, Caforio ALP, Feltrin G,
Toscano G, Valente M, Thiene G, Gerosa G.
14
CURRICULUM VITAE
Antibody-mediated rejection without acute graft dysfunction
in adult ABO-compatible heart transplantation: a case of
accommodation. J Heart Lung Transplant; 2008
Dec;27(12):1357-60. I.F. 3.087
- 121) Cooper LT Jr, Hare JM, Tazelaar HD, Edwards WD,
Starling RC, Deng MC, Menon S, Mullen GM, Jaski B,
Bailey KR, Cunningham MW, Dec GW; Giant Cell
Myocarditis Treatment Trial Investigators. Usefulness of
immunosuppression for giant cell myocarditis. Am J Cardiol
2008 Dec 1;102(11):1535-9. I.F. 3.603
- 122) Leone O, Rapezzi C, Sinagra G, Angelini A, Arbustini
E, Bartoloni G, Basso C, Caforio ALP, Calabrese F,
Coccolo F, d’Amati G, Maresi E, Milanesi O, Nodari S, Oliva
F, Perkan A, Prandstraller D, Pucci A, Ramondo R, Silvestri
F, Valente ML, Thiene G. Federazione Italiana di
Cardiologia. Documento di consenso sulla biopsia
endomiocardica promosso dall’Associazione per la
Patologia Cardiovascolare Italiana. G Ital Cardiol 2009; 10
(Suppl 1-9): 1-50.
15
RETRIBUZIONE ANNUA LORDA RISULTANTE DAL CONTRATTO INDIVIDUALE
Amministrazione: AZIENDA OSPEDALIERA DI PADOVA
dirigente: ALIDA LINDA PATRIZIA CAFORIO
incarico ricoperto: Staff - Cardiologia
stipendio tabellare
€ 0,00
posizione parte
fissa
€ 0,00
posizione parte
variabile
€ 0,00
retribuzione di
risultato
€ 0,00
TOTALE ANNUO
LORDO
altro*
€ 0,00
€ 0,00
*ogni altro emolumento retributivo non ricompreso nelle voci precedenti
16